Peraso Inc. receives Nasdaq minimum bid price warning with 180-day compliance window
Small-cap technology listings have faced sustained valuation pressure across markets, and Peraso Inc. is now navigating the formal consequences. The San Jose, California company received a letter dated July 21, 2026, from the…
Key takeaways
- Peraso Inc. (Nasdaq: PRSO) received a letter dated July 21, 2026 from Nasdaq stating its stock closed below the $1 minimum bid price for 30 consecutive business days through July 20, breaching Nasdaq Listing Rule 5550(a)(2).
- Under Rule 5810(c)(3)(A), Peraso has 180 calendar days—until January 19, 2027—to regain compliance by keeping its closing bid price at or above $1 for at least ten consecutive business days.
- If Peraso fails to comply by January 19, 2027, it may qualify for a second 180-day period by meeting certain Nasdaq initial listing standards and providing written notice of intent to cure, potentially via a reverse stock split.
- The notice does not trigger immediate delisting, but Nasdaq retains authority to begin delisting proceedings if it concludes the company cannot remedy the deficiency.
- Peraso's board set September 10, 2026 as the date for its virtual 2026 Annual Meeting of Stockholders, with a record date of July 20, 2026.
Small-cap technology listings have faced sustained valuation pressure across markets, and Peraso Inc. is now navigating the formal consequences. The San Jose, California company received a letter dated July 21, 2026, from the Nasdaq Listing Qualifications Staff confirming that its common stock (ticker: PRSO) closed below the exchange's $1 minimum bid price for 30 consecutive business days through July 20, a breach of Nasdaq Listing Rule 5550(a)(2).
The compliance clock and what it requires
Under Nasdaq Listing Rule 5810(c)(3)(A), Peraso has 180 calendar days to regain compliance, with the deadline set at January 19, 2027. The cure condition is specific: the closing bid price must hold at or above $1 per share for at least ten consecutive business days during that period. Chief Financial Officer James Sullivan signed the filing, which states the company is monitoring its closing bid price and weighing available options.
A second path, with conditions attached
If Peraso does not meet the threshold by January 19, 2027, a second 180-day compliance period may be available. That path requires Peraso to satisfy the Nasdaq Capital Market's initial listing standards for market value of publicly held shares, meet all other initial listing criteria except the bid price requirement, and provide written notice to Nasdaq of its intent to cure the deficiency. A reverse stock split is named in the filing as a potential mechanism. Nasdaq retains authority to initiate delisting proceedings if it concludes the company cannot remedy the situation or is otherwise ineligible for the extension.
Annual meeting added to the calendar
Separately, Peraso's board set September 10, 2026 as the date for the company's 2026 Annual Meeting of Stockholders, to be held virtually. Shareholders of record as of July 20, 2026 are entitled to vote. Stockholder proposals under Rule 14a-8 and director nominations must reach the company secretary by 5:00 p.m. Eastern time on August 3, 2026. The same date applies to notices under the SEC's universal proxy rules for any shareholder intending to solicit proxies for director nominees other than the company's own candidates.
The read-through for small-cap exchange access
Deficiency notices of this type are a standard output of Nasdaq's listing qualification process. The letter Peraso received on July 21 does not trigger immediate removal from the Nasdaq Capital Market. What it does is start a formal clock, placing the company's continued exchange listing squarely before its board and shareholders ahead of January 19, 2027.
Source · 來源